View Full Paper

Owner Consent Verified
Policy Brief 4.9

Hospitality Management for Pharmaceutical Firms: Cost–Benefit Analysis | A Comparative Perspective

7
Pages
Chicago
Style
~ 7–13 mins
Reading Time
Cybersecurity CV IoT
Abstract

This policy brief investigates “Hospitality Management for Pharmaceutical Firms: Cost–Benefit Analysis | A Comparative Perspective” using a event study methodology. Through a institutional lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.

Download PDF Order Similar Paper Save

Hospitality Management for Pharmaceutical Firms: Cost–Benefit Analysis | A Comparative Perspective

ABSTRACT
Hospitality Management for Pharmaceutical Firms: Cost–Benefit Analysis | A Comparative Perspective is unpacked across themes: interoperability, costs, equity, and governance. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
20 Pages 4.4
Telemedicine and Adoption Barriers among Microfinance Institutions — 2025–2027 Trends
HCI InsurTech Metaverse
View Paper
29 Pages 4.7
Change Management in Hydrogen Economy for Cross-functional Tech Teams: A qualitative grounded theory
Finance AI InsurTech
View Paper
10 Pages 4.4
Food Security for Pharmaceutical Firms: Resilience And Continuity | Evidence from Benelux
Sociology BioMed UX
View Paper